Literature DB >> 18213574

Dendritic cells are required for effective cross-presentation in the murine liver.

George Plitas1, Bryan M Burt, Jennifer A Stableford, Hoang M Nguyen, Alexander P Welles, Ronald P DeMatteo.   

Abstract

UNLABELLED: The liver harbors a diversity of cell types that have been reported to stimulate T cells. Although most hepatic dendritic cells are immature, a small population of CD11c(high) conventional dendritic cells (cDCs) exists that expresses high levels of costimulatory molecules. We sought to determine the relative contribution of cDCs to cross-presentation by the liver. In vitro, liver nonparenchymal cells (NPCs) depleted of cDCs induced only minimal proliferation and activation of antigen-specific CD8(+) T cells when loaded with soluble protein antigen. Using a transgenic mouse with the CD11c promoter driving expression of the human diphtheria toxin receptor, we found that selective depletion of cDCs in vivo reduced the number and activation of antigen-specific CD8(+) T cells in the liver after intravenous administration of soluble protein antigen. Adoptive transfer of DCs, but not CD40 stimulation, restored the hepatic T-cell response.
CONCLUSION: Our findings indicate that the ability of the liver to effectively cross-present soluble protein to antigen-specific CD8(+) T cells depends primarily on cDCs. Despite costimulation, other resident liver antigen-presenting cells cannot compensate for the absence of cDCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18213574     DOI: 10.1002/hep.22167

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  16 in total

Review 1.  Studying the mononuclear phagocyte system in the molecular age.

Authors:  Andrew Chow; Brian D Brown; Miriam Merad
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

Review 2.  Immune mechanisms in acetaminophen-induced acute liver failure.

Authors:  Oliver Krenkel; Jana C Mossanen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

3.  Dendritic cell depletion exacerbates acetaminophen hepatotoxicity.

Authors:  Michael K Connolly; Diego Ayo; Ashim Malhotra; Michael Hackman; Andrea S Bedrosian; Junaid Ibrahim; Napoleon E Cieza-Rubio; Andrew H Nguyen; Justin R Henning; Monica Dorvil-Castro; H Leon Pachter; George Miller
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

4.  Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver.

Authors:  Junaid Ibrahim; Andrew H Nguyen; Adeel Rehman; Atsuo Ochi; Mohsin Jamal; Christopher S Graffeo; Justin R Henning; Constantinos P Zambirinis; Nina C Fallon; Rocky Barilla; Sana Badar; Aaron Mitchell; Raghavendra S Rao; Devrim Acehan; Alan B Frey; George Miller
Journal:  Gastroenterology       Date:  2012-06-12       Impact factor: 22.682

5.  Identification of the cellular sensor that stimulates the inflammatory response to sterile cell death.

Authors:  Hajime Kono; Dipti Karmarkar; Yoichiro Iwakura; Kenneth L Rock
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

6.  DAP12 promotes IRAK-M expression and IL-10 production by liver myeloid dendritic cells and restrains their T cell allostimulatory ability.

Authors:  Tina L Sumpter; Vignesh Packiam; Heth R Turnquist; Antonino Castellaneta; Osamu Yoshida; Angus W Thomson
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

Review 7.  Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.

Authors:  Tim Chan; Robert H Wiltrout; Jonathan M Weiss
Journal:  Int Immunopharmacol       Date:  2011-01-15       Impact factor: 4.932

8.  Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion.

Authors:  Zubin M Bamboat; Lee M Ocuin; Vinod P Balachandran; Hebroon Obaid; George Plitas; Ronald P DeMatteo
Journal:  J Clin Invest       Date:  2010-01-19       Impact factor: 14.808

9.  In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha.

Authors:  Michael K Connolly; Andrea S Bedrosian; Jon Mallen-St Clair; Aaron P Mitchell; Junaid Ibrahim; Andrea Stroud; H Leon Pachter; Dafna Bar-Sagi; Alan B Frey; George Miller
Journal:  J Clin Invest       Date:  2009-10-12       Impact factor: 14.808

10.  Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilities.

Authors:  Tim Chan; Timothy C Back; Jeffrey J Subleski; Jonathan M Weiss; John R Ortaldo; Robert H Wiltrout
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.